A critical function of toll-like receptor-3 in the induction of anti-human immunodeficiency virus activities in macrophages.

Immunology
Y ZhouWenzhe Ho

Abstract

Toll-like receptor-3 (TLR-3) recognizes double-stranded RNA and induces multiple intracellular events responsible for innate anti-viral immunity against a number of viral infections. Activation of TLR-3 inhibits human immunodeficiency virus (HIV) replication, but the mechanism(s) underlying the action of TLR-3 activation on HIV are largely unknown. Here we demonstrate that treatment of monocyte-derived macrophages with poly I:C, a synthetic ligand for TLR-3, significantly inhibited HIV infection and replication. Investigation of the mechanisms showed that TLR-3 activation resulted in the induction of type I interferon inducible antiviral factors, including APOBEC3G and tetherin, the newly identified anti-HIV cellular proteins. In addition, poly I:C-treated macrophages expressed increased levels of CC chemokines, the ligands for CCR5. Furthermore, TLR-3 activation in macrophages induced the expression of cellular microRNAs (miRNA-28, -125b, -150, -223 and -382), the newly identified intracellular HIV restriction factors. These findings indicate that TLR-3-mediated induction of multiple anti-HIV factors should be beneficial for the treatment of HIV disease where innate immune responses are compromised by the virus.

References

Jan 24, 1998·Nature·E A BergerR A Weiss
Feb 28, 2002·Annual Review of Immunology·Charles A Janeway, Ruslan Medzhitov
Jun 18, 2003·Community Genetics·Ronald P van Rij, Hanneke Schuitemaker
Jul 16, 2003·Cell·Roberto MarianiNathaniel R Landau
Jun 26, 2004·Journal of Leukocyte Biology·Robert D Stout, Jill Suttles
Jul 2, 2004·Nature Reviews. Immunology·Shizuo Akira, Kiyoshi Takeda
Mar 16, 2005·Biochemical and Biophysical Research Communications·Emi HamanoNaoto Keicho
Apr 23, 2005·Science·Charles-Henri LecellierOlivier Voinnet
Aug 23, 2005·Trends in Immunology·Fanny N LauwDouglas T Golenbock
Oct 21, 2005·Biochemical and Biophysical Research Communications·Manoj HariharanSamir K Brahmachari
Dec 3, 2005·Nature Reviews. Immunology·Siamon Gordon, Philip R Taylor
Feb 25, 2006·Cell·Shizuo AkiraOsamu Takeuchi
Oct 24, 2006·Pharmacology & Therapeutics·György HaskóE Sylvester Vizi
Nov 7, 2006·Journal of Molecular Neuroscience : MN·Monique LafonChristophe Prehaud
Dec 13, 2006·Current Opinion in Immunology·Dieter Kabelitz, Ruslan Medzhitov
Jan 11, 2007·Médecine sciences : M/S·Yves DelnestePascale Jeannin
May 5, 2007·Nature Medicine·Holger KanzlerRobert L Coffman
Oct 19, 2007·Nature·Irene M PedersenMichael David
Nov 23, 2007·Biochemical Society Transactions·D R AverettJ R Appleman
Jan 9, 2008·Immunology and Cell Biology·Mohammed AlsharifiMatthias Regner
Jan 10, 2008·Journal of Leukocyte Biology·Laura Adalid-PeraltaUNKNOWN Interprim ANRS 112 Study Group
Jan 18, 2008·Nature·Stuart J D NeilPaul D Bieniasz
Aug 22, 2008·Journal of Virology·Stephane DaffisMichael S Diamond
Nov 26, 2008·Journal of Neuroimmunology·Yan-Jian WangWen-Zhe Ho
Dec 20, 2008·Nucleic Acids Research·Zhumur GhoshJayprokas Chakrabarti

❮ Previous
Next ❯

Citations

Jul 31, 2013·Immunobiology·Sabina VictoriaDumith Chequer Bou-Habib
Sep 18, 2012·The Journal of Biological Chemistry·Aisha Qasim ButtSinéad M Miggin
Oct 5, 2012·Innate Immunity·Yu ZhouWenzhe Ho
Jan 23, 2016·Cytokine & Growth Factor Reviews·Mieke De BuckJo Van Damme
Apr 5, 2016·Immunity, Inflammation and Disease·Wadie D Mahauad-Fernandez, Chioma M Okeoma
Nov 20, 2015·Frontiers in Microbiology·Xu WangWen-Zhe Ho
Sep 1, 2015·Hepatitis Monthly·Yizhong WangWenzhe Ho
Dec 10, 2013·Journal of Molecular Biology·Sandra N Lester, Kui Li
Nov 6, 2013·Journal of Molecular Biology·Belete A DesimmieVinay K Pathak
Dec 29, 2013·Journal of Molecular Biology·Gokul SwaminathanJulio Martín-García
Mar 19, 2014·Blood·Silvio Antoniak, Nigel Mackman
May 2, 2014·Frontiers in Microbiology·Daniel Sauter
Oct 7, 2016·Advances in Biological Regulation·Yoe-Sik BaePann-Ghill Suh
Sep 9, 2016·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Yu ZhouWen-Zhe Ho
Aug 25, 2015·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ming DaiWen-Zhe Ho
May 10, 2020·European Journal of Immunology·Agnès Garcias LópezKatharina Lahl
Sep 24, 2020·International Journal of Molecular Sciences·Sergey BrezginVladimir Chulanov
Mar 23, 2017·Frontiers in Immunology·Xu WangWen-Zhe Ho
Oct 11, 2017·Frontiers in Medicine·Amarpreet KaurDavid A Schwartz
Sep 27, 2018·Frontiers in Immunology·Nicole Grandi, Enzo Tramontano
Aug 21, 2019·Cells·Louis BergantzClémence Richetta
Aug 30, 2020·International Journal of Molecular Sciences·Huy NguyenVishwanath Venketaraman
Nov 19, 2020·Microorganisms·Edward P Browne

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.